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level was elevated (374 pg/ml; reference range, 
125 pg/ml). Next, the patient experienced new­
­onset hand numbness (primarily in the  left 
hand), indicating carpal tunnel syndrome with 
neural compression. This led us to change the ten­
tative diagnosis from HCM to cardiac amyloido­
sis.1,2 We performed 99mTc ­3, 3 ­diphosphono ­1, 
2 ­propanodicarboxylic acid scintigraphy, which 
showed radiotracer uptake in the heart, typical 
of ATTR.1,2
Genetic analysis revealed the ATTR variant 
c.325G>A (p.Glu109Lys). This variant E109K in 
the TTR gene cannot be found in the ClinVar da­
tabase; however, 2 other substitutions in the po­
sition of 109 in the TTR gene have been report­
ed as pathogenic (E109Q) or of uncertain signif­
icance (E109D). This finding supports the diag­
nosis of ATTR.
The GLS polar plot map did not provide any 
conclusive findings. However, scintigraphy yield­
ed strong evidence supporting the diagnosis of 
Transthyretin amyloidosis (ATTR) is a protein­
­misfolding disease, in which amyloid fibrils in­
filtrate the myocardium.1 On echocardiography, 
ATTR may present as a phenocopy of hypertrophic 
cardiomyopathy (HCM). Several diagnostic tools 
may facilitate the diagnosis, such as echocardiog­
raphy, scintigraphy, biomarkers, or genetic analy­
sis.1 We report a case that highlights the role of car­
diac biomarkers, extracardiac symptoms, and ge­
netic analysis in the differential diagnosis of car­
diac amyloidosis.
A 47 ­year ­old man with heart failure (New 
York Heart Association class II) and suspicion of 
HCM or amyloidosis was referred to our hospi­
tal for further diagnostic workup. Doppler echo­
cardiography revealed asymmetric left ventricu­
lar (LV) septal hypertrophy (2.2 cm during dias­
tole; FIGurE 1A) with preserved LV ejection frac­
tion (61%), and LV outflow tract gradient of 
22 mm Hg at rest and 36 mm Hg after provoca­
tion. The ratio of early to late diastolic transmi­
tral flow velocity (E/A) was 1.6, indicating a non­
restrictive filling pattern. The global longitudi­
nal strain (GLS) was preserved in the apical seg­
ments, and there was no “apical sparing” pattern 
typical for ATTR. The mean GLS was –18.3%, but 
there was a marked abnormal gradient of defor­
mation between the basic and apical segments 
(minimum value, –4%; maximum value, –32%; 
FIGurE 1B). For comparison, FIGurE 1C shows a total­
ly abnormal GLS pattern of a patient with more 
advanced ATTR.2
The patient had normal high ­sensitive tropo­
nin I (hs ­TnI, 9.3 ng/ml) and N ­terminal fragment 
of the prohormone brain natriuretic peptide (NT­
­proBNP, 98.5 pg/ml) levels (double ­negative bio­
markers), which might be explained by an early 
stage of the disease. A year later, the NT ­proBNP 
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A
FIGurE 1 Echocardiography findings showing: 
A – asymmetric left ventricular septal hypertrophy 
characteristic of hypertrophic cardiomyopathy
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ATTP confirmed by genotyping. The patient pre­
sented with normal hs ­TnI and NT ­proBNP levels 
despite several echocardiographic features typi­
cal of HCM with mild obstruction. Therefore, we 
postulate that the normal levels of hs ­TnI and NT­
­proBNP may help distinguish HCM from ATTR 
(at an early stage of the disease).
Our hypothesis could be useful in interpret­
ing the study by Zhang et al.3 The authors did 
not provide data on the minimal value of NT­
­proBNP in the HCM subgroup with negative 
troponin results, but observed very high medi­
an and lower quartile NT ­proBNP values (medi­
an [IQR], 1166.7 [775.5–1818.5] pg/ml). Proba­
bly, there were no troponin / NT ­proBNP–negative 
patients. In the Methods section, the authors did 
not mention that the HCM phenocopies were ex­
cluded. They did not use any specific tests or ex­
aminations for a differential diagnosis of ATTR. 
It might be speculated, in our opinion, that some 
patients with HCM and normal NT­proBNP lev­
els had undiagnosed ATTR.
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FIGurE 1  
Echocardiography findings 
showing: B – a near‑
‑normal global longitudinal 
strain pattern without 
typical features of 
transthyretin amyloidosis, 
seen in our patient; 
C – an abnormal global 
longitudinal strain pattern 
typically seen in patients 
with advanced ATTR
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